January 16, 2024—Gore & Associates announced that the first patients have been enrolled in the Gore VBX FORWARD clinical study. The global prospective, multicenter, randomized controlled trial is comparing the company’s Viabahn VBX balloon expandable endoprosthesis—the VBX stent graft—versus bare…
Gore VBX FORWARD Clinical Study Enrolls First Patients
